Clovis Oncology, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-27: Reporting owner McKinley Edward J; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-27: Reporting owner McKinley Edward J; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-06-14: Reporting owner ATWOOD BRIAN G; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-06-14: Reporting owner BLAIR JAMES C; Form 4; Security Stock Option (Right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-27 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,862 0 owned after | $0.29 exercise price | 2012-12-31 | |
| 2012-12-27 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,896 0 owned after | $3.08 exercise price | 2012-12-31 | |
| 2012-06-14 | ATWOOD BRIAN G Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 57,585 owned after | $19.46 exercise price | 2012-06-18 | |
| 2012-06-14 | BLAIR JAMES C Director, 10% Owner | 4 | Stock Option (Right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $19.46 exercise price | 2012-06-18 | |
| 2012-06-14 | KLINGENSTEIN PAUL H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $19.46 exercise price | 2012-06-18 | |
| 2012-06-14 | BARRETT M JAMES Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −12,414 12,414 owned after | $19.46 exercise price | 2012-06-18 | |
| 2012-06-14 | REED JOHN C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $19.46 exercise price | 2012-06-15 | |
| 2012-06-14 | SPICKSCHEN THORLEF Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $19.46 exercise price | 2012-06-15 | |
| 2012-06-14 | McKinley Edward J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,414 12,414 owned after | $19.46 exercise price | 2012-06-15 | |
| 2012-03-01 | MAST ERLE T Officer (Executive VP and CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $24.74 exercise price | 2012-03-05 | |
| 2012-03-01 | MAHAFFY PATRICK J Director, Officer (President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $24.74 exercise price | 2012-03-05 | |
| 2012-03-01 | Allen Andrew R Officer (SEE REMARKS) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $24.74 exercise price | 2012-03-05 | |
| 2012-03-01 | Hoerter Steven L. Officer (SEE REMARKS) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $24.74 exercise price | 2012-03-05 | |
| 2012-03-01 | IVERS-READ GILLIAN C Officer (SEE REMARKS) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $24.74 exercise price | 2012-03-05 |